Intellia Therapeutics, based in Cambridge, MA, is a pioneering biotechnology company dedicated to transforming the lives of individuals with severe diseases through the development of potentially curative genome editing treatments.
With a focus on innovative CRISPR-based therapies, Intellia Therapeutics is committed to pushing the boundaries of medicine and opening a new era in healthcare, all while prioritizing patient well-being and empowerment.
Generated from the website